| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC3796 |
| Trial ID | NCT06304636 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | Descartes-15 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Descartes-15 for Patients With Relapsed/Refractory Multiple Myeloma |
| Year | 2024 |
| Country | United States |
| Company sponsor | Cartesian Therapeutics |
| Other ID(s) | DC15-MM-01 |
| Cohort 1 | |||||||||
|
|||||||||